欧州・中東の慢性疼痛向け脊髄刺激装置市場規模・予測（2020年～2030年）、世界・地域シェア、動向、成長機会分析レポート収録範囲製品タイプ別（充電式、非充電式）、用途別（腰痛症、複合性局所疼痛症候群、変性椎間板疾患、その他）、エンドユーザー別（病院、外来手術センター（ASCs）、その他）、地域別分析

Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type (Rechargeable and Non-Rechargeable), Application (Failed Back Syndrome, Complex Regional Pain Syndrome, Degenerative Disk Disease, and Others), End User [Hospitals, Ambulatory Surgery Centers (ASCs), and Others], and Regional Analysis

欧州・中東の慢性疼痛用脊髄刺激装置市場は、2022年の8億9,200万米ドルから2030年には15億7,300万米ドルに成長すると予想され、2022年から2030年までの年平均成長率は7.3％と予測されている。脊髄損傷の増加や欧... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
The Insight Partners ザ・インサイトパートナーズ	2023年11月28日	US$3,450 シングルユーザライセンスライセンス・価格情報注文方法はこちら	204	英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

欧州・中東の慢性疼痛用脊髄刺激装置市場は、2022年の8億9,200万米ドルから2030年には15億7,300万米ドルに成長すると予想され、2022年から2030年までの年平均成長率は7.3％と予測されている。脊髄損傷の増加や欧州連合（EU）における革新的な治療法の利用可能性は、欧州・中東の慢性疼痛用脊髄刺激装置市場の成長を促進するいくつかの要因である。
脊髄刺激装置は、低レベルの電気を脊髄に直接流して痛みを和らげる埋め込み装置である。脊髄刺激装置は、非外科的な疼痛治療の選択肢で十分な緩和が得られなかった後に使用されることがほとんどである。また、脊髄刺激装置は、生活や睡眠の質を全体的に改善し、鎮痛薬の必要性を減らすことができます。脊髄刺激装置は通常、他の疼痛管理治療とともに使用される。

欧州連合における革新的治療の利用可能性
欧州委員会が発表した報告書によると、脊髄損傷は感覚喪失を伴う運動障害、慢性疼痛、その他の運動機能障害を引き起こす原因となっている。そのため、欧州連合（EU）では、脊髄損傷患者のためのリハビリテーション・プログラムがいくつか実施されている。脊髄修復プロジェクト（SCRP）もそのひとつで、EUの科学者が学際的に協力している。SCRPは、脊髄損傷後の運動機能や動作といった身体的な動きを回復させることを目的としている。このプログラムの下で、臨床試験の一環として、ネズミの運動動作を標準化するための実験装置-MotoRater-が開発され、商標登録された。これらのげっ歯類は、運動機能を担うEphA4などの興奮性中枢パターン発生器（CPG）ニューロンの細胞特性を同定し、特徴付けるために利用された。CPGは脊髄にある神経回路で、CPGニューロンとそのシナプス相互作用の相互作用からリズミカルな運動を刺激する。臨床研究の成果は、会議や学会を通じて発表され、特許が申請され、出版された。したがって、EUにおける脊髄障害の治療における現在進行中の技術革新は、脊髄損傷に苦しむ何百万人もの人々の移動と生活の質の向上に役立っている。

数社のバイオ製薬会社が、脊髄損傷治療のための革新的な製品を開発している。スウェーデンのバイオファーマ企業であるバイオアークティック社は、中枢神経系（CNS）障害の治療法の開発に専念している。例えば、2019年2月、BioArctic社は、損傷した脊髄に外科的に移植する生分解性医療機器「SC0806」を開発した。SCO806」を移植すると、このデバイスは脊髄の損傷部位を横切って神経線維を誘導する。SCIを治療するための競合他社によるこのような革新的な製品の発売は、欧州と中東における慢性疼痛用脊髄刺激装置の市場成長を後押ししている。

市場動向
再生可能で革新的なインプラントを用いた治療アプローチ
マドリッド自治州は、細胞療法と再生療法を用いた脊髄損傷の治療をEUで初めて行ったと主張している。再生医療には、脊髄損傷患者から間葉系幹細胞を抽出し、抽出した細胞を細胞製造室で処理し、再生した細胞を脊髄損傷の正確な部位または脳脊髄液（CSF）に注入することが含まれる。したがって、この技術はSCIの個別化治療となる。

欧州委員会は2022年9月に報告書を発表し、科学者たちが脳卒中の回復を助けるために、グラフェンベースのインプラントやバーチャルリアリティ（VR）ゲームを使ってSCIを治療する新しい方法を開発していることを明らかにした。科学者たちは、神経損傷を回復させるためにこうした新しいアプローチを試みている。一方、グラフェンなどの人工材料を用いて、脊髄の構造をその場で再構築しようと試みる研究者もいる。グラフェンは、脊髄の形態を巧みに模倣する3D構造を作り出すために使用される。したがって、このような革新的な人工材料とインプラントを使用することで、脊髄損傷に苦しむ患者の治療の可能性を示すことに成功している。再生可能で革新的なインプラントを用いた治療アプローチは、欧州と中東の慢性疼痛用脊髄刺激装置市場の新たなトレンドとして台頭してきている。

欧州・中東の慢性疼痛向け脊髄刺激装置市場」は、製品タイプ、用途、エンドユーザー、地域に基づいて区分される。製品タイプに基づき、慢性疼痛用脊髄刺激装置市場は充電式と非充電式に二分される。充電式セグメントは2022年に最大の市場シェアを占め、同セグメントは2022-2030年に大きなCAGRを記録すると予測されている。用途別では、慢性疼痛用脊髄刺激装置は、故障性腰痛症候群、複合性局所疼痛症候群、変性ディスク疾患、その他に区分される。複合性局所疼痛症候群セグメントは2022年に最大の市場シェアを占め、同セグメントは予測期間2020-2030年に最も高いCAGRを記録すると予測されている。エンドユーザー別では、慢性疼痛用脊髄刺激装置は病院、外来手術センター、その他に分類される。病院セグメントは2022年に市場でより大きなシェアを占め、2022-2030年に高いCAGRを記録すると予測されている。

2023年9月、レゾナント・リンク社とCirtec Medical Corp社は、植込み型医療機器の未来を切り開くために提携した。レゾナント・リンクの次世代ワイヤレス・パワーとCirtec Medicalの専門的な製品設計、開発、製造サービスを組み合わせることで、この提携は医療機器メーカーに最高の技術、完全に統合されたコンポーネント、市場投入までの時間の短縮を提供する。

ページTOPに戻る

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
1.2.1 Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – by Product Type
1.2.2 Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – by Application
1.2.3 Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – by End User
1.2.4 Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – by Region
2. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Market Landscape
4.1 Overview
4.1.1 Europe and Middle East PEST Analysis
5. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market
5.1 Market Drivers
5.1.1 Rising Number of Spinal Cord Injuries
5.1.2 Availability of Innovative Treatments in European Union
5.2 Market Restraints
5.2.1 Product Recalls
5.3 Market Opportunities
5.3.1 Rehabilitation and Specialized Centers Providing Effective Treatment for Spinal Cord Injuries
5.4 Future Trends
5.4.1 Regenerative and Innovative Implant-Based Therapeutic Approaches
5.5 Impact analysis
6. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Regional Analysis
6.1 Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market Revenue Forecast and Analysis
7. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 – by Product Type
7.1 Overview
7.2 Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by Product Type, 2022 & 2030 (%)
7.3 Rechargeable
7.3.1 Overview
7.3.2 Rechargeable: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Non-Rechargeable
7.4.1 Overview
7.4.2 Non-Rechargeable: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)
8. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecasts To 2030– by Application
8.1 Overview
8.1.1 Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by Application (2022 and 2030)
8.2 Failed Back Syndrome
8.2.1 Overview
8.2.2 Failed Back Syndrome: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market– Revenue and Forecast to 2030 (US$ Million)
8.3 Complex Regional Pain Syndrome
8.3.1 Overview
8.3.2 Complex Regional Pain Syndrome: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Degenerative Disk Disease
8.4.1 Overview
8.4.2 Degenerative Disk Disease: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)
9. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecasts To 2030– by End User
9.1 Overview
9.2 Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by End User (2022 and 2030)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market– Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgery Centers (ASCs)
9.4.1 Overview
9.4.2 Ambulatory Surgery Centers (ASCs): Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)
10. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 – Regional Analysis
10.1 Europe Spinal Cord Stimulation Device for Chronic Pain Market, Revenue and Forecast To 2030
10.1.1 Overview
10.1.2 Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.1 Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
10.1.2.2 Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
10.1.2.3 Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
10.1.2.4 Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by Countries
10.1.2.5 Germany
10.1.2.5.1 Overview
10.1.2.5.2 Germany: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.5.3 Germany: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
10.1.2.5.4 Germany: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
10.1.2.5.5 Germany: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
10.1.2.6 France
10.1.2.6.1 Overview
10.1.2.6.2 France: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.6.3 France: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
10.1.2.6.4 France: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
10.1.2.6.5 France: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
10.1.2.7 Italy
10.1.2.7.1 Overview
10.1.2.7.2 Italy: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.7.3 Italy: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
10.1.2.7.4 Italy: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
10.1.2.7.5 Italy: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
10.1.2.8 Spain
10.1.2.8.1 Overview
10.1.2.8.2 Spain: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.8.3 Spain: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
10.1.2.8.4 Spain: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
10.1.2.8.5 Spain: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
10.1.2.9 United Kingdom
10.1.2.9.1 Overview
10.1.2.9.2 United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.9.3 United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
10.1.2.9.4 United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
10.1.2.9.5 United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
10.1.2.10 Switzerland
10.1.2.10.1 Overview
10.1.2.10.2 Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.10.3 Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
10.1.2.10.4 Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
10.1.2.10.5 Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
10.1.2.11 Netherlands
10.1.2.11.1 Overview
10.1.2.11.2 Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.11.3 Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
10.1.2.11.4 Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
10.1.2.11.5 Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
10.1.2.12 Sweden
10.1.2.12.1 Overview
10.1.2.12.2 Sweden: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.12.3 Sweden: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
10.1.2.12.4 Sweden: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
10.1.2.12.5 Sweden: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
10.1.2.13 Belgium
10.1.2.13.1 Overview
10.1.2.13.2 Belgium: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.13.3 Belgium: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
10.1.2.13.4 Belgium: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
10.1.2.13.5 Belgium: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
10.1.2.14 Poland
10.1.2.14.1 Overview
10.1.2.14.2 Poland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.14.3 Poland: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
10.1.2.14.4 Poland: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
10.1.2.14.5 Poland: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
10.1.2.15 Slovakia
10.1.2.15.1 Overview
10.1.2.15.2 Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.15.3 Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
10.1.2.15.4 Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
10.1.2.15.5 Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
10.1.2.16 Czech Republic
10.1.2.16.1 Overview
10.1.2.16.2 Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.16.3 Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
10.1.2.16.4 Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
10.1.2.16.5 Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
10.1.2.17 Greece
10.1.2.17.1 Overview
10.1.2.17.2 Greece: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.17.3 Greece: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
10.1.2.17.4 Greece: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
10.1.2.17.5 Greece: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
10.1.2.18 Ireland
10.1.2.18.1 Overview
10.1.2.18.2 Ireland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.18.3 Ireland: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
10.1.2.18.4 Ireland: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
10.1.2.18.5 Ireland: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
10.1.2.19 Rest of Europe
10.1.2.19.1 Overview
10.1.2.19.2 Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.19.3 Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
10.1.2.19.4 Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
10.1.2.19.5 Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
11. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 – Regional Analysis
11.1 Middle East Spinal Cord Stimulation Device for Chronic Pain Market, Revenue and Forecast To 2030
11.1.1 Overview
11.1.2 Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.1 Middle East: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
11.1.2.2 Middle East: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
11.1.2.3 Middle East: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
11.1.2.4 Middle East: Spinal Cord Stimulation Device for Chronic Pain Market, by Countries
11.1.2.5 Qatar
11.1.2.5.1 Overview
11.1.2.5.2 Qatar: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.5.3 Qatar: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
11.1.2.5.4 Qatar: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
11.1.2.5.5 Qatar: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
11.1.2.6 Saudi Arabia
11.1.2.6.1 Overview
11.1.2.6.2 Saudi Arabia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.6.3 Saudi Arabia: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
11.1.2.6.4 Saudi Arabia: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
11.1.2.6.5 Saudi Arabia: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
11.1.2.7 UAE
11.1.2.7.1 Overview
11.1.2.7.2 UAE: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.7.3 UAE: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
11.1.2.7.4 UAE: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
11.1.2.7.5 UAE: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
11.1.2.8 Turkey
11.1.2.8.1 Overview
11.1.2.8.2 Turkey: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.8.3 Turkey: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
11.1.2.8.4 Turkey: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
11.1.2.8.5 Turkey: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
11.1.2.9 Israel
11.1.2.9.1 Overview
11.1.2.9.2 Israel: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.9.3 Israel: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
11.1.2.9.4 Israel: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
11.1.2.9.5 Israel: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
11.1.2.10 Rest of Middle East
11.1.2.10.1 Overview
11.1.2.10.2 Rest of Middle East: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.10.3 Rest of Middle East: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
11.1.2.10.4 Rest of Middle East: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
11.1.2.10.5 Rest of Middle East: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Boston Scientific Corp
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Abbott Laboratories
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Medtronic Plc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Curonix LLC
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Biotronik SE & Co KG
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Nevro Corp
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Nalu Medical Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Cirtec Medical Corp
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Synapse Biomedical Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms

ページTOPに戻る

Table of Contents

Summary

The Europe and Middle East spinal cord stimulation devices for chronic pain market is expected to grow from US$ 0.892 billion in 2022 to US$ 1.573 billion by 2030; it is expected to grow at a CAGR of 7.3% from 2022 to 2030. rising number of spinal cord injuries and the availability of innovative treatments in the European Union (EU) are a few factors driving the Europe and Middle East spinal cord stimulation devices for chronic pain market growth.
A spinal cord stimulation device is an implanted device that sends low levels of electricity directly into the spinal cord to relieve pain. A spinal cord stimulator is mostly used after non-surgical pain treatment options that have failed to provide sufficient relief. Additionally, a spinal cord stimulator can improve the overall quality of life and sleep and reduce the need for pain medicines. It is typically used along with other pain management treatments.

Availability of Innovative Treatments in the European Union
According to a report published by the European Commission, SCI is responsible for causing motor impairment with sensation loss, chronic pain, and other locomotor dysfunction. Therefore, in the European Union (EU), several rehabilitation programs are being conducted for patients living with SCIs. The SPINAL CORD REPAIR Project (SCRP) is one such example that is a multidisciplinary collaboration among EU scientists. The SCRP is responsible for restoring physical movements such as motor function or movement after SCIs. Under this program, an experimental setup—MotoRater—was developed and trademarked for the standardized testing of locomotion movements among rodents as a part of clinical testing. These rodents were utilized to identify and characterize the cellular properties of excitatory central pattern generator (CPG) neurons such as EphA4, which are responsible for locomotion. CPG is a neural circuit in the spinal cord that stimulates rhythmic movements from the interplay between CPG neurons and their synaptic interactions. The clinical research results were presented through meetings and congresses; patents were filed and published. Therefore, the ongoing innovations in the treatments of spinal cord disorders in the EU help improve the mobility and quality of life for millions suffering from SCI.

Several biopharma companies are developing innovative products to treat SCIs. BioArctic, a Swedish biopharma company, is dedicated to developing treatments for central nervous system (CNS) disorders. For instance, in February 2019, BioArctic developed "SC0806," a biodegradable medical device that is surgically implanted into an injured spinal cord. Upon the implantation of "SCO806," the device guides nerve fibers across the injured area in the spinal cord. Such innovative product launches by competitive players to treat SCI fuel the growth of spinal cord stimulation devices for the chronic pain market in Europe and the Middle East.

Market Trend
Regenerative and Innovative Implant-Based Therapeutic Approaches
The Comunidad de Madrid claims to be the first in the EU to provide treatments for SCIs using cell and regenerative therapy. Regenerative medicine includes the extraction of mesenchymal stem cells from patients suffering SCIs, treating the extracted cells in a cell production room, and then injecting the regenerated cells at the exact site of SCI or into the cerebrospinal fluid (CSF). Thus, this technique serves as a personalized treatment for SCIs.

The European Commission published a report in September 2022 revealing that scientists are developing new ways to treat SCI using graphene-based implants and virtual reality (VR) gaming to help improve stroke recovery. Scientists are trying these new approaches to reverse nerve damage, while some researchers are attempting to reshape the architecture of the spinal cord in situ by using engineered materials such as graphene. Graphene is used to create a 3D structure that would skillfully mimic the morphology of the spinal cord. Therefore, the use of such innovative engineered materials and implants successfully exhibits the treatment potential in patients suffering from SCIs. The regenerative and innovative implant-based therapeutic approaches are emerging as new trends in Europe and the Middle East spinal cord stimulation devices for the chronic pain market.

The “Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Market” is segmented on the basis of product type, application, end-user, and region. Based on product type, the spinal cord stimulation devices for chronic pain market is bifurcated into rechargeable and non-rechargeable. The rechargeable segment held the largest market share in 2022, and the same segment is expected to record a significant CAGR during 2022–2030. Based on application, the spinal cord stimulation devices for the chronic pain market are segmented as failed back syndrome, complex regional pain syndrome, degenerative disk disease, and others. The complex regional pain syndrome segment held the largest market share in 2022, and the same segment is anticipated to register the highest CAGR for the forecast period 2020-2030. In terms of end users, the spinal cord stimulation devices for the chronic pain market are categorized into hospitals, ambulatory surgery centers, and others. The hospital segment held a larger share of the market in 2022 and is anticipated to register a higher CAGR during 2022–2030.

In September 2023, Resonant Link and Cirtec Medical Corp partnered to power the future of implantable medical devices. By combining Resonant Link’s next-generation wireless power with Cirtec Medical’s expert product design, development, and manufacturing services, this partnership will offer medical device makers the best technology, fully integrated components, and faster time to market.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療機器）の最新刊レポート

The Insight Partners社の医療機器分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療機器）の最新刊レポート

The Insight Partners社の医療機器分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?